Good point Halpowith CardioCel®.
This is out of the half yearly-
In this period, Admedus made significant progress getting CardioCel® into cardiothoracic
surgery centres across Europe and the US. By the end of the current period, 23 European
centres and 20 centres in the US had used the product. These numbers have since risen
further to 27 centres in Europe and 25 centres in the US, with over 1,000 patients implanted
I read this as, half yearly was out on the 27 of Feb.
so that was 20 days ago
200 ops in 20 days
That's pretty good.
Ann: Admedus expands CardioCel market, page-8
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.75 | $46.16K | 2.581K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.91 | 32 | 2 |
View Market Depth
| Last trade - 13.54pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |